David Milroy
Partner
Specialism
Growth,
IFS Maven Equity Finance
Maven Office
Edinburgh
Primary Geographical Focus
UK
Recent Investments
Podfather (logistics software), PowerPhotonic (high power laser optics), Esk (high-end live experiences), Metrion (specialist CRO), Nami Surgical (next-generation tools for robotic surgery), Dxcover (early cancer detection) and Approov (mobile security). Notable exits - Quorum Cyber, Optoscribe , QikServe, Blacktrace, Calnex, Crawford Scientific, Endura, Symphonic, PrismTech, Vermilion and Novatus.
Key Sector Experience
Life Sciences, Healthcare, Deep Tech, IT/Cyber and Software.
David joined Maven’s then parent, Aberdeen Asset Management, in 2007 and heads up Maven’s Edinburgh office. He focuses on sourcing and executing growth capital and private equity investments in Scotland as well as technology and life science investments across the UK.
David started his career as a scientist with GSK. After completing his PhD, he moved to international consultancy firm Wood Mackenzie (and then parent Deutsche Bank) where he supported the healthcare banking team, advising clients on their corporate and licensing strategies; and performing due diligence projects on companies, products and technologies. David joined Aberdeen Asset Management’s private equity division (spun-out to form Maven in 2009) in September 2007 as Fund Manager for an early-stage technology fund.
David has a First Class Honours degree, a PhD (Molecular Biology/Gene Delivery) from the University of Bath and a MBA with distinction from Edinburgh University.
Outside of work David enjoys competing in triathlons, sailing, skiing and trying to keep up with his two sons.